Tubule‐Derived IFN‐α Promotes GSDMD‐Mediated Macrophage Pyroptosis to Drive Renal Inflammation and Fibrosis Through JAK2/STAT2 Activation
Source abstract
Abstract
Abstract Macrophages exhibit high plasticity in response to tubular epithelial cell (TEC) injury. Gasdermin D (GSDMD)‐mediated pyroptosis amplifies the inflammatory and fibrogenic cascade, yet its role in chronic kidney disease (CKD) remains elusive. Herein, GSDMD is upregulated in kidney macrophages following unilateral renal ischemia‐reperfusion injury (UIRI) or folic acid‐induced injury, paralleling elevated pyroptosis rates. Clinically, the active fragment GSDMD‐N localizes primarily to CD68⁺ macrophages, and its renal level positively correlates with fibrosis severity across diverse CKD etiologies, reinforcing its pathogenic relevance. Macrophage‐specific deletion of Gsdmd ameliorates pyroptosis, inflammation, and renal fibrosis in both murine models, without affecting acute tubular damage in bilateral IRI. Mechanistically, injured TECs initiate this cascade through secreted IFN‐α, which activates the IFNAR1/JAK2/STAT2 axis in macrophages. STAT2 then forms a complex with IRF9, directly binding to the Gsdmd promoter to transcriptionally upregulate GSDMD expression. Genetic ablation of Jak2 , Stat2 , or Ifnar1 reduces GSDMD and GSDMD‐N levels and inhibits IL‐1β/IL‐18 secretion. Notably, administration of an IFN‐α neutralizing antibody attenuates UIRI‐induced pyroptotic macrophage, inflammation, and renal fibrosis. Collectively, the findings uncover a STAT2/IRF9‐dependent paracrine IFN‐α feedback loop that orchestrates GSDMD‐mediated pyroptosis, linking injured TECs to macrophage‐driven renal inflammation and fibrosis. Targeting this axis represents a promising strategy to halt CKD progression.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Inflammasome and immune disorders · Acute Kidney Injury Research · Nephrotoxicity and Medicinal Plants
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Nephrology The First Affiliated Hospital Sun Yat‐sen University Guangzhou 510080 China
Department of Nephrology NHC Key Laboratory of ClinicalNephrology (Sun Yat-Sen University) and Guangdong Provincial Key Laboratory ofNephrology Guangzhou 510080 China
Basic andTranslational Medical Research Center, Sun Yat-sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Guangdong Province
References (57)
Show source-provided references
1. 10.1016/S2214-109X(23)00570-310.1016/S2214-109X(23)00570-3 ↗
2. 10.1038/s41581-019-0248-y10.1038/s41581-019-0248-y ↗
3. 10.1038/s41392-023-01379-710.1038/s41392-023-01379-7 ↗
4. 10.1038/s41581-019-0110-210.1038/s41581-019-0110-2 ↗
5. 10.1002/advs.20230975210.1002/advs.202309752 ↗
6. 10.1111/j.1523-1755.2005.00422.x10.1111/j.1523-1755.2005.00422.x ↗
7. 10.1681/ASN.201305052810.1681/ASN.2013050528 ↗
8. 10.1038/s41467-024-47315-310.1038/s41467-024-47315-3 ↗
9. 10.1161/HYPERTENSIONAHA.121.1875010.1161/HYPERTENSIONAHA.121.18750 ↗
10. 10.1038/s41467-021-27034-910.1038/s41467-021-27034-9 ↗
11. 10.1038/s41573-021-00154-z10.1038/s41573-021-00154-z ↗
12. 10.1038/s41419-023-06005-610.1038/s41419-023-06005-6 ↗
13. 10.1016/j.smim.2023.10178110.1016/j.smim.2023.101781 ↗
14. 10.1038/s41419-022-04910-w10.1038/s41419-022-04910-w ↗
15. 10.1038/s41590-023-01526-w10.1038/s41590-023-01526-w ↗
16. 10.1038/s41577-019-0165-010.1038/s41577-019-0165-0 ↗
17. 10.1016/j.apsb.2021.10.00610.1016/j.apsb.2021.10.006 ↗
18. 10.1038/s41419-020-2323-510.1038/s41419-020-2323-5 ↗
19. 10.1161/ATVBAHA.123.32061210.1161/ATVBAHA.123.320612 ↗
20. 10.1038/s41419-022-05138-410.1038/s41419-022-05138-4 ↗
21. 10.7150/thno.7229110.7150/thno.72291 ↗
22. 10.1038/s41467-023-36614-w10.1038/s41467-023-36614-w ↗
23. 10.1016/j.cell.2024.10.01010.1016/j.cell.2024.10.010 ↗
24. 10.1681/ASN.201901006810.1681/ASN.2019010068 ↗
25. 10.1038/nature1344910.1038/nature13449 ↗
26. 10.1038/s41586-021-03341-510.1038/s41586-021-03341-5 ↗
27. 10.1073/pnas.171842611510.1073/pnas.1718426115 ↗
28. 10.1038/s41467-019-10970-y10.1038/s41467-019-10970-y ↗
29. 10.1016/j.cell.2022.09.02310.1016/j.cell.2022.09.023 ↗
30. 10.1038/s41392-023-01468-710.1038/s41392-023-01468-7 ↗
31. 10.1152/ajprenal.00487.201210.1152/ajprenal.00487.2012 ↗
32. 10.1038/s41423-019-0343-910.1038/s41423-019-0343-9 ↗
33. 10.1038/s41392-024-01958-210.1038/s41392-024-01958-2 ↗
34. 10.2147/JIR.S48855310.2147/JIR.S488553 ↗
35. 10.1038/s41586-024-08022-710.1038/s41586-024-08022-7 ↗
36. 10.1016/j.jdermsci.2022.12.00610.1016/j.jdermsci.2022.12.006 ↗
37. 10.1016/j.immuni.2017.11.01310.1016/j.immuni.2017.11.013 ↗
38. 10.1038/s41420-022-00894-w10.1038/s41420-022-00894-w ↗
39. 10.1016/j.cell.2024.11.01810.1016/j.cell.2024.11.018 ↗
40. 10.1038/s41418-021-00755-610.1038/s41418-021-00755-6 ↗
41. 10.1681/ASN.201608084010.1681/ASN.2016080840 ↗
42. 10.1681/ASN.201708086310.1681/ASN.2017080863 ↗
43. 10.1016/j.immuni.2005.01.00510.1016/j.immuni.2005.01.005 ↗
44. 10.1038/cr.2013.4710.1038/cr.2013.47 ↗
45. 10.1038/s41590-024-01804-110.1038/s41590-024-01804-1 ↗
46. 10.1681/ASN.000000057710.1681/ASN.0000000577 ↗
47. 10.1093/cvr/cvae11710.1093/cvr/cvae117 ↗
48. 10.1016/j.intimp.2024.11349810.1016/j.intimp.2024.113498 ↗
49. 10.3389/fimmu.2024.148920510.3389/fimmu.2024.1489205 ↗
50. 10.3389/fphar.2022.104668710.3389/fphar.2022.1046687 ↗
51. 10.1016/j.immuni.2024.09.00410.1016/j.immuni.2024.09.004 ↗
52. 10.1016/j.kint.2024.04.01610.1016/j.kint.2024.04.016 ↗
53. 10.1002/advs.20230691210.1002/advs.202306912 ↗
54. 10.1016/j.kint.2019.04.03510.1016/j.kint.2019.04.035 ↗
55. 10.1158/0008-5472.CAN-22-119910.1158/0008-5472.CAN-22-1199 ↗
56. 10.1016/j.xpro.2020.10024610.1016/j.xpro.2020.100246 ↗
57. 10.1002/advs.20230060410.1002/advs.202300604 ↗